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Background: This study aimed to evaluate the association between preoperative level of physical
functioning and time to recovery of physical functioning, postoperative complications, and the impact of
postoperative major complications in patients undergoing elective pancreatic resection. Additionally,
prediction models to identify high-risk patients for developing a major complication were externally
validated.
Methods: Perioperative data of patients who underwent pancreatic resection were analysed. Primary
outcomes were time to recovery of physical functioning and postoperative major complications. Impact
of a major complication was explored by evaluating its effect on time to recovery of physical functioning.
Risk-prediction models were retrieved following a systematic review.
Results: Multivariable analysis (n = 63) showed that ASA grade III (OR 3.498) and preoperative platelet
count (OR 1.005) were associated with major complications, whereas aerobic capacity (OR 0.347) was
associated with time to recovery of physical functioning. Age, preoperative aerobic capacity, functional
mobility, and perceived level of functional capacity were associated with the impact of a major
complication. The AUC of two risk prediction models were 0.556 and 0.701.
Conclusion: Preoperative parameters of physical function were associated with postoperative out-
comes and may be useful in outcome prediction, although future approaches should not only register the
incidence of major complications but also take the impact of a complication on a patient’s physical
functioning into account.Received 4 March 2019; accepted 16 September 2019Correspondence
Christel van Beijsterveld, Maastricht University, Faculty of Health, Medicine and Life Sciences, Care and
Public Health Research Institute (CAPHRI), Department of Epidemiology, Deb 1, room A2.010, PO Box
616, 6200 MD, Maastricht, the Netherlands. E-mail: c.vanbeijsterveld@maastrichtuniversity.nlIntroduction
Patients diagnosed with cancer in the pancreas often experience
disease-related symptoms (e.g., loss of body mass, jaundice, loss
of appetite, nausea), which also induce changes in skeletal muscleHPB 2020, 22, 716–727 © 2019 International Hepato-Pmass and in the function of a variety of organs leading to
functional impairments.1 Surgical resection is the only poten-
tially curative modality. However, pancreatic resection is associ-
ated with a high risk of perioperative morbidity (36–60%) andancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
HPB 717mortality (2.9–3.5%).2–4 Patients and their (in)formal caregivers
should together make a well-informed decision about the risk-
benefit ratio for undergoing major abdominal surgery with or
without preoperative preventive interventions, and the options
for additional or non-surgical cancer-directed treatment as a
(palliative) alternative.5,6 Several prediction models exist to
preoperatively estimate the risk of postoperative morbidity and
mortality,7–9 which can be used to support decision-making with
the patient and their (in)formal caregivers when considering
pancreatic resection. However, there is a wide variability in the
selection of preoperative factors and the definition of post-
operative outcomes in risk models. Some have included opera-
tive factors (e.g., type of surgery, operation time, blood loss),10,11
making them more difficult to utilize during preoperative
counselling of patients. Other risk models focus merely on one
specific type of complication, mostly pancreatic fistula.12,13
Moreover, as external – pragmatic clinical – validation of
available evidence-based risk models is scarce and risk models
are thought to not outweigh the surgeon’s assessment, they
currently play a very limited role in clinical practice.14,15
Patient’s tolerance for surgery depends on their ability to adapt
to the stress of hospitalization (e.g. decreased physical activity16)
and surgery (e.g. hormonal and metabolic disturbances17).
Especially those patients developing a complication after
pancreatic surgery should have enough reserve capacity to cope
with the increased psychophysiological load.18,19 Some studies
have shown that preoperative aerobic capacity is associated with
postoperative morbidity, mortality, and length of stay in patients
undergoing pancreatic resection.20–22 Besides aerobic capacity,
also muscle strength, functional mobility, and the patient’s
physical activity level in daily life are considered as indicators for
the adaptive capacity of the patient, as they are associated with
postoperative time to recovery of physical functioning,
morbidity, and mortality following major abdominal sur-
gery.23–25 If a patient has significant perioperative risk factors
(e.g., low aerobic fitness, malnutrition, anemia), appropriate
preoperative preventive interventions should be initiated by
means of personalized multimodal prehabilitation. Optimizing a
patient’s psychophysiological reserves prior to surgery is
increasingly considered beneficial for recovery functioning, as it
reduces the risk for morbidity, and mortality following major
abdominal surgery.26,27 Furthermore, it is hypothesized that
psychophysiological reserve capacity is associated with the
impact of any complication, in which the impact of a post-
operative event is expected to be lower in patients with higher
levels of physical fitness. The first aim of this study was to
evaluate the association between the preoperative level of phys-
ical functioning and postoperative outcomes in patients with
pancreatic cancer opting for pancreatic resection. In addition, we
aimed to assess the external validity of prediction models that
have been developed to preoperatively identify patients with a
higher risk for developing a major complication after pancreatic
resection. The number of patients who develop complicationsHPB 2020, 22, 716–727 © 2019 International Hepato-Pafter pancreatic resection is high and fitter patients might also
develop a complication. It should be noted that fitter patients
might demonstrate enhanced coping with a complication,
reducing its impact and resulting in better postoperative out-
comes. Hence, the final aim of the current study was to explore
whether the patient’s preoperative level of physical functioning
was associated with the impact of major postoperative
complications.Methods
Study design
This single-center prospective cohort study evaluated post-
operative outcomes (time to recovery of physical functioning,
major complications and their impact) in patients with pancre-
atic or periampullary carcinoma undergoing elective pancreatic
resection.
Participants
Patients with pancreatic tumors (adenocarcinoma of the
pancreatic head, duodenum, ampulla of Vater, and lower bile
duct, or neuro-endocrine tumors), primary benign tumors (e.g.,
intraductal papillary mucinous neoplasm of the pancreas), and
metastases in the pancreas who were scheduled for curative
pancreatic resection based on input from a multidisciplinary
team of medical specialist (surgeons, oncologists, radiologists,
pathologist, radiotherapist, gastroenterologists) at the Maastricht
University Medical Center (Maastricht UMC+) between March
2016 and July 2018 were included. Exclusion criteria were
pancreatic resection for acute or chronic pancreatitis (except
when there was a suspicion for malignancy), a primary tumor
outside the pancreas with only secondary involvement of the
pancreas, pancreas preserving bile duct resection, and explor-
atory surgery without pancreas resection. Additionally, patients
who had not undergone screening of physical functioning as part
of preoperative assessment because of logistical issues, or those
who were screened on their level of physical functioning, but did
not opt for surgery, were excluded. All consecutive patients with
no objection for using their usual care data for research purposes
were included. The medical ethical committee of the Maastricht
UMC + decided (reference number 15-4-234) that this study met
the ethical policies of the Maastricht UMC+.
Patient journey
Patients scheduled for curative pancreatic resection were
consecutively referred to the outpatient physical therapy
department by the hepato-pancreatic-biliary (HPB) surgeon or
clinical nurse specialist for screening of physical functioning as
part of multidisciplinary preoperative assessment. A hospital
physical therapist with expertise in the hepato-pancreato-biliary
(HPB) surgical field conducted the preoperative screening. The
preoperative screening included tests to estimate the patient’s
aerobic capacity (modified steep ramp test [SRT], a short-timeancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
718 HPBmaximal exercise test on a cycle ergometer), muscle strength
(handgrip strength [HGS]), functional mobility (five times sit-
to-stand [FTSTS] test, timed up-and-go [TUG] test, and 2-
minute walking test [2MWT]), and perceived level of func-
tional capacity to perform activities of daily life (veterans-specific
activity questionnaire [VSAQ] and Duke activity status index
[DASI], both expressed in metabolic equivalents of task [METs]).
An extensive description of the used measurement protocols for
the preoperative screening of physical functioning is provided in
the online Supplementary File 1.
All patients were educated (verbally and by using information
leaflets) regarding the importance of an adequate preoperative
level of physical functioning, and were advised to stay physically
active throughout the pre- and postoperative phase. All patients
were routinely admitted one day prior to surgery to the HPB
surgical ward. Postoperatively, patients were admitted to the HPB
surgical ward as soon as possible, unless admission to the
intensive care unit was warranted due to intra-operative events
or postoperative complications. All patients received post-
operative physical therapy once a day (starting at postoperative
day 1) focusing on airway clearing exercises and regaining
functional independence by early mobilisation, adapted to the
individual patient’s needs and progress.28–30 Recovery of physical
functioning was monitored using the modified Iowa level of
assistance scale (mILAS), scoring on the ability to perform five
functional tasks.31,32 Patients were discharged when analgesia,
wound healing, organ functions, laboratory parameters, dietary
intake, and recovery of physical functioning (mILAS) were
considered adequate by the clinical team.
Pre- and postoperative outcomes, including
monitoring of the patient’s level of physical
functioning
Preoperative clinical data collected from all patients consisted of
patient demographics and anthropometrics (e.g., age, sex, body
height, body mass), comorbidities, American Society of Anes-
thesiologists (ASA) grade, functional status (scored on the
eastern cooperative oncology group [ECOG] scale33), smoking
status, chronic steroid use, preoperative sepsis, preoperative in-
terventions (e.g., neoadjuvant treatment, biliary drainage,
nutritional support), preoperative blood parameters (e.g., he-
moglobin concentration, white blood cell count, platelet count,
creatinine level, albumin level), and preoperative level of physical
functioning (e.g., aerobic capacity, handgrip strength, functional
mobility, and perceived level of functional capacity to perform
activities of daily life). These preoperative variables were selected
based on a literature search34–36 and usual care procedures as
applied by the department of HPB surgery and department of
physical therapy.
Postoperative data included pathology-specific information,
surgical procedures, time to recovery of physical functioning,
postoperative complications, and length of hospital stay. Time to
recovery of physical functioning was defined as the time betweenHPB 2020, 22, 716–727 © 2019 International Hepato-Pthe day of surgery and the day at which patients reached a
mILAS score of 0 (in days). Time to recovery of physical func-
tioning was also dichotomized according to the median time to
recovery of physical functioning. Postoperative complications
were classified following the criteria of the international study
group for pancreatic surgery (ISGPS) for pancreatic fistula,37
delayed gastric emptying,38 hemorrhage,39 and chyle leakage.40
Biliary leakage was classified according to the definition of the
international study group of liver surgery.41 The incidence of
postoperative complications as events were graded using the
Clavien-Dindo classification.42 Complications graded with I or
II were defined as minor and complications between III and V
were defined as major. Impact of these events, especially the
major complications, was explored by calculating composite
endpoints.
Selection of risk models to predict risk for major
complications
The transparent reporting of a multivariable prediction model
for individual prognosis or diagnosis (TRIPOD) guideline was
used for the external validation of available risk models.43 A
systematic literature search was performed in PubMed to
identify cohort studies developing models to predict the risk
for major complications following pancreatic resection
published within the last ten years (Supplemental File 2).
Studies were included when they (i) comprised a study pop-
ulation of patients (>18 years) undergoing elective pancreatic
resection, (ii) evaluated preoperative patient-related risk factors
in relation to postoperative morbidity, (iii) provided quanti-
tative indicators concerning the association between preoper-
ative patient-related variables and postoperative morbidity, and
(iv) proposed a clinically interpretable risk-model. Studies were
excluded when they merely predicted one particular compli-
cation (e.g., pancreatic fistula) or used intraoperative pre-
dictors. The study selection process is available in the online
Supplementary File 2.
Association between preoperative physical
functioning and the impact of postoperative major
complications
The impact of a major complication was explored by evaluating
its effect on time to recovery of physical functioning. Hereto, two
composite endpoints were defined to enable the comparison of
two subgroups of patients with a different impact of a major
complication. One group of patients with a major complication
and a time to recovery of physical functioning above its median
value in this study cohort (higher impact) and a group of patients
with a major complication and a time to recovery of physical
functioning below its median value (lower impact). To explore
whether a patient’s preoperative level of physical functioning was
associated with the impact of a major postoperative complica-
tion, preoperative characteristics were compared between the
two subgroups.ancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
Table 1 Demographics, preoperative characteristics, and post-
operative outcomes of the study cohort (n = 63)
All
Demographics
Sex ratio (M:F) 31:32
Age (years)a 68 (26–85)
<70 33 (52.4)
70 30 (47.6)
BMI (kg/m2)a 25.6 (19.1–39.3)
Normal (18.5–24.9) 27 (42.9)
Overweight (25.0–29.9) 30 (47.6)
Obese (30.0) 6 (9.5)
ASA
Grade I– II 46 (73.0)
Grade  III 17 (27.0)
Comorbidities
None 15 (23.8)
1 comorbidity 14 (22.2)
2 comorbidities 34 (54.0)
Cardiac 17 (27.0)
Vascular 24 (38.1)
Pulmonary 12 (19.0)
Diabetes 6 (9.5)
Gastrointestinal 13 (20.6)
Neurological 8 (12.7)
Functional status
Independent 49 (77.8)
Dependent 14 (22.2)
Current smoking
No 51 (81.0)
Yes 12 (19.0)
Chronic steroid use
No 63 (100.0)
Yes 0 (0.0)
Preoperative sepsis
No 63 (100.0)
Yes 0 (0.0)
Biliary drainage
No 31 (49.2)
Yes 32 (50.8)
Additional nutrition
No 37 (49.2)
Yes 26 (41.3)
Neoadjuvant treatment
No 59 (93.7)
Yes 4 (6.3)
(continued on next column)
Table 1 (continued )
All
Preoperative physical functioninga
SRT (WRpeak) 173.0 (56.0–308.0)
SRT (WRpeak/kg) 2.29 (0.92–4.12)
HGS (kg) 31.0 (15.0–68.0)
FTSTS test (s) 8.25 (3.69–30.5)
TUG test (s) 5.32 (3.32–21.25)
2MWT (m) 172.0 (55.0–245.0)
VSAQ (MET) 8.0 (2.0–12.0)
DASI (MET) 6.6 (3.1–9.9)
Laboratory values All
Hemoglobin (g/dL)a 12.5 (7.0–16.4)
Thrombocytes (103 cells/mm3)a 278 (141–683)
WBC (103 cells/mm3)a 8.4 (1.1–18.0)
Creatinine (mg/dL) 1.4 2 (3.2)
Albumin (g/dL) 3.4 29 (46.0)
Operative characteristics
Type of surgery
PPPD 43 (68.3)
Whipple 4 (6.3)
Distal pancreatectomy 13 (20.6)
Other 3 (4.8)
Histologic diagnosis
Adenocarcinoma 42 (66.7)
Neuroendocrine tumors 10 (15.9)
Benign cystic lesions 6 (9.5)
Other 5 (7.9)
Postoperative outcomes
No complications 19 (30.2)
Grade I– II 17 (27.0)
Grade III 13 (20.6)
Grade IV 11 (17.5)
Grade V 3 (4.8)
Pancreatic fistula
None 51 (81.0)
Grade A 0 (0.0)
Grade B 11 (17.5)
Grade C 1 (1.6)
Delayed gastric emptying
None or grade A 48 (76.2)
Grade B 5 (7.9)
Grade C 10 (15.9)
Hemorrhage
None or grade A 55 (87.3)
Grade B 7 (11.1)
Grade C 1 (1.6)
(continued on next page)
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Table 1 (continued )
All
Biliary leakage
None of grade A 57 (90.5)
Grade B 5 (7.9)
Grade C 1 (1.6)
Chyle leakage
None 52 (82.5)
Grade A 5 (7.9)
Grade B 6 (9.5)
Grade C 0 (0.0)
Wound infection 5 (7.9)
Pneumonia 7 (11.1)
Cardiac arrhythmias 2 (3.2)
Reintervention 24 (38.1)
Admission to ICU 14 (22.2)
Length of hospital staya 14 (6–78)
Time to recovery of physical functioninga 6.5 (1–49)
Abbreviations: ASA = American Society of Anesthesiologists;
BMI = body mass index; DASI = Duke activity status index;
FTSTS = five times sit-to-stand; HGS = hand grip strength;
ICU=Intensive care unit; MET = metabolic equivalent of task;
PPPD = pylorus-preserving pancreaticoduodenectomy; SRT = steep
ramp test; TUG = timed up-and-go; VSAQ = veterans-specific activity
questionnaire; WBC = white blood cells; WRpeak = peak work rate;
2MWT = two-minute walk test.
a Values are expressed as median (range).
720 HPBStatistical analysis
The Statistical Package for the Social Sciences for Windows
(version 23.0; IBM, SPSS Inc., Chicago, IL, USA) was used for
statistical analysis. For continuous variables, normality was tested
with the Kolmogorov–Smirnov test. Missing preoperative lab-
oratory values or results on preoperative physical functioning
tests were imputed using multiple imputation with ten iterations
for each imputation. To analyse the association between preop-
erative level of physical functioning and postoperative outcomes,
the Mann–Whitney U test was used for continuous variables and
Fisher’s exact test was used for categorical variables. All variables
with P-values <0.05 in univariate analysis were included in a
multivariable logistic regression model with backward stepwise
elimination (with ten events per variable). A combination of
conventional and physical functioning predictors were chosen
based on level of statistical significance and expert opinion. To
evaluate the performance of the available risk models, discrim-
ination and calibration of the risk scores were assessed for each
model.44 Receiver operating characteristics (ROC) curve analysis
was performed, and the discriminative ability of the prediction
models was quantified as the area under the curve (AUC). The
model’s calibration evaluates the agreement between the
observed probability and predicted probability of postoperative
complications, and is illustrated using a calibration plot. AHPB 2020, 22, 716–727 © 2019 International Hepato-Pregression coefficient of 1 and an intercept of zero represents
perfect calibration of the model. To explore the impact of a major
complication, the two subgroups of patients with a different
impact of a major complication were compared using the
Mann–Whitney U test for the continuous variables and the
Fisher’s exact test for categorical variables. A P-value <0.05 was
considered statistically significant.Results
Pre- and postoperative outcomes with monitoring of
the patient’s level of physical functioning
A total of 79 patients diagnosed with pancreatic or periampullary
carcinoma and opting for resection with preoperative assessment
of physical functioning between February 2016 and July 2018
were considered for the study. Sixteen patients (20.3%) were
excluded retrospectively, as intraoperative findings resulted in no
surgical resection being performed. Hence, 63 patients (79.7%)
were available for analysis following pancreatic resection.
Mean ± SD time between preoperative screening of physical
functioning and surgery was 23.6 ± 21.0 days. Patient de-
mographics, preoperative variables, and postoperative outcomes
of the study cohort are listed in Table 1. Fig. 1 gives an illustrative
overview of the pre-and postoperative level of physical func-
tioning of three individual patients following pancreatic resec-
tion for pancreatic cancer. A total of 44 patients (69.8%)
developed a complication of which major complications (Clav-
ien-Dindo classification  III) occurred in 27 patients (42.9%).
The median time to recovery of physical functioning was 6.5 days
(range 1–49) and median length of hospital stay was 14 days
(range 6–78 days).
Univariable analysis (Table 2) demonstrated that age, ASA
grade (III versus I–II), and preoperative platelet count (103 cells/
mm3) were associated with the occurrence of major complica-
tions (P < 0.05). Multivariable logistic regression with stepwise
elimination yielded a model including two variables predicting
these events. ASA grade III versus I–II (odds ratio [OR] of 1.498;
95% confidence interval [CI] of 1.033–11.852; P = 0.044) and
preoperative platelet count (OR of 1.005 per 103 cells/mm3; 95%
CI of 1.000–1.010; P = 0.038) (Table 3). The AUC for this model
was 0.740 (95% CI 0.617 to 0.863; P = 0.001). Furthermore,
univariable analysis for recovery of physical functioning showed
that age, aerobic capacity (relative SRT performance, WRpeak in
W/kg), functional mobility (2MWT distance, in m), preoperative
perceived level of functional capacity to perform ADL (VSAQ
and DASI, both in METs), and preoperative white blood cell
count (103 cells/mm3) were associated with mILAS-data for time
to recovery of physical functioning (Table 2). Multivariable lo-
gistic regression with stepwise elimination starting with three
variables (age in years, SRT performance in W/kg, and 2MWT
distance in m) yielded a model predicting time to recovery of
physical functioning above its median value in this study cohort
from relative SRT performance (OR of 0.347; 95% CIancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
Figure 1 Illustrative overview of the pre-and postoperative level of physical functioning of individual patients (n = 3) with pancreatic cancer
following pancreatic resection
HPB 7210.141–0.854; P = 0.021). The AUC for relative SRT performance
was 0.680 (95% CI 0.545 to 0.815; P = 0.014).
Selection and performance of risk prediction models
Three preoperative risk prediction models for pancreatic surgery
were identified in the literature (Supplemental File 2,
Table 1).8,9,34 The number of predictors ranged from five to ten
(Supplemental File 2, Table 2). One model could not be validated
because of insufficient information, even after contacting the
authors.8 The authors closed the online risk prediction tool, as it
was based on “outdated information”. Hence, two models9,32
were externally validated within the present study cohort. The
models had a discriminative ability (AUC) of 0.701
(0.565–0.838)9 and 0.556 (0.413–0.698),32 respectively. The
calibration plots showed a poor agreement between the observed
and predicted probabilities, and both models - on average -
underestimated the risk of major complications in the present
study cohort (Fig. 2).
Composite outcomes
In total, 27 patients (42.9%) developed a major complication, of
which 22 patients (81.5%) experienced a time to recovery of
physical functioning above its median value (n = 19) or deceased
(n = 3) (composite endpoint 1), whereas five of these patients
(18.5%) experienced a time to recovery of physical functioning
below its median value (composite endpoint 2). When preoper-
ative demographics and level of physical functioning data were
clustered according to composite endpoints (Table 4), a clinically
relevant and statistically significant difference between both
groups was observed in age (years), preoperative aerobic capacity
(relative SRT performance, meaning the absolute SRTHPB 2020, 22, 716–727 © 2019 International Hepato-Pperformance in Watt normalized for the patient’s body mass [W/
kg]), functional mobility (2MWT, in m), and perceived level of
functional capacity to perform activities of daily life (DASI, in
METs) (P < 0.05).Discussion
In this study, we found that conventional factors (ASA grade III
and platelet count) were associated with developing major
complications, whereas aerobic capacity (SRT performance) was
associated with time to recovery of physical functioning. External
validation of two available preoperative prediction models for the
risk of major complications demonstrated moderate-to-good
ability to discriminate between individuals with and without a
major complication. However, these prediction models under-
estimated the risk for major complications in the current study
population. Explorative analysis demonstrated that age and
preoperative physical functioning might be related with the
impact of a major complication for a patient.
The current study confirms that preoperative tests of phys-
ical functioning (SRT and 2MWT) were associated with time to
recovery of physical functioning (Table 2). This is congruent
with other studies evaluating the relation between preoperative
performance-based tests of physical functioning and post-
operative time to recovery of physical functioning in similar
patient populations.23,24 Conventional preoperative factors
(ASA grade III and preoperative platelet count) were associated
with the development of postoperative major complications
(Table 2). The presence of preoperative thrombocytosis
(increased platelet count >500 × 109/L) has been shown to be
associated with morbidity after distal pancreatectomy34 andancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
Table 2 Preoperative variables and postoperative outcomes with frequency of complications according to Clavien-Dindo and time to re-
covery of physical functioning according to the modified Iowa level of assistance scale
Major complicationsa Time to recovery of physical functioningb
Present (n [ 27) Absent (n [ 36) P ‡7 days (n [ 33) £6 days (n [ 30) P
Sex ratio (M:F) 15:12 16:20 0.450 18:15 13:17 0.453
Age (years)c 72.0 (26.0–85.0) 63.5 (37.0–78.0) 0.032 71.0 (26.0–85.0) 65.5 (37.0–78.0) 0.035
<70 10 (37.0) 23 (63.9) 0.044 14 (42.4) 19 (63.3) 0.131
70 17 (63.0) 13 (36.1) 19 (57.6) 11 (36.7)
BMI (kg/m2)c 26.1 (19.1–39.3) 24.5 (20.6–35.2) 0.743 26.2 (19.1–39.3) 24.7 (20.6–31.6) 0.148
Normal (18.5–24.9) 10 (37.0) 17 (47.2) 0.466 11 (33.3) 16 (53.3) 0.146
Overweight (25.0–29.9) 13 (48.1) 17 (47.2) 17 (51.1) 13 (43.3)
Obese (30.0) 4 (14.8) 2 (5.6) 5 (15.2) 1 (3.3)
ASA 0.046 0.268
Grade I– II 16 (59.3) 30 (83.3) 22 (66.7) 24 (80.0)
Grade  III 11 (40.7) 6 (16.7) 11 (33.3) 6 (20.0)
Comorbidities 0.078 0.093
None 4 (14.8) 11 (30.6) 5 (15.2) 10 (33.3)
1 comorbidity 4 (14.8) 10 (27.8) 6 (18.2) 8 (26.7)
2 comorbidities 19 (70.4) 15 (41.7) 22 (66.7) 12 (40.0)
Functional status 0.124 0.373
Independent 18 (66.7) 31 (86.1) 24 (72.7) 25 (83.3)
Dependent 9 (33.3) 5 (13.9) 9 (27.3) 5 (16.7)
Current smoking 0.531 0.202
No 23 (85.2) 28 (77.8) 29 (87.9) 22 (73.3)
Yes 4 (14.8) 8 (22.2) 4 (12.1) 8 (26.7)
Biliary drainage 0.801 1.000
No 14 (51.9) 17 (47.2) 16 (48.5) 15 (50.0)
Yes 13 (48.1) 19 (52.8) 17 (51.5) 15 (50.0)
Additional nutrition 1.000 0.306
No 16 (59.3) 21 (58.3) 17 (51.5) 20 (66.7)
Yes 11 (40.7) 15 (41.7) 16 (48.5) 10 (33.3)
Neoadjuvant treatment 0.629 0.340
No 26 (96.3) 33 (91.7) 32 (97.0) 27 (90.0)
Yes 1 (3.7) 3 (8.3) 1 (3.0) 3 (10.0)
Physical functioningc
SRT (WRpeak) 168.0 (67.0–301.0) 183.5 (56.0–308.0) 0.128 169.0 (67.0–301.0) 184.0 (56.0–308.0) 0.091
SRT (WRpeak/kg) 2.21 (0.92–4.12) 2.3 (0.92–3.89) 0.161 2.21 (0.92–3.26) 2.56 (0.92–4.12) 0.013
HGS (kg) 32.0 (15.0–59.0) 30.5 (17.0–68.0) 0.844 31.0 (15.0–59.0) 30.5 (17.0–68.0) 0.899
FTSTS test (s) 8.66 (4.78–28.93) 8.16 (3.69–30.50) 0.501 9.09 (3.69–28.93) 7.38 (4.63–30.50) 0.072
TUG test (s) 4.91 (3.32–21.25) 5.45 (3.53–19.41) 0.409 5.81 (3.32–21.25) 4.58 (3.53–19.41) 0.135
2MWT (m) 165.0 (55.0–240.0) 175.0 (55.0–245.0) 0.144 163.0 (55.0–195.0) 177.0 (55.0–245.0) 0.010
VSAQ (MET) 8.0 (3.0–11.0) 8.0 (2.0–12.0) 0.397 7.0 (3.0–11.0) 9.0 (2.0–12.0) 0.032
DASI (MET) 6.3 (3.1–9.9) 7.3 (3.6–9.9) 0.103 6.3 (3.1–9.9) 7.3 (3.6–9.9) 0.045
Laboratory values
Hemoglobin (g/dL)c 12.3 (7.0–15.7) 12.7 (9.7–16.4) 0.146 12.5 (7.0–16.4) 12.6 (9.72–15.6) 0.997
Platelet count (103 cells/mm3)c 310 (183–683) 248 (141–467) 0.019 286 (141–683) 258 (167–467) 0.333
WBC (103 cells/mm3)a 9.8 (4.3–18.0) 8.0 (1.1–16.6) 0.318 9.8 (1.1–18.0) 7.6 (5.5–14.0) 0.043
HPB 2020, 22, 716–727 © 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
722 HPB
Table 2 (continued )
Major complicationsa Time to recovery of physical functioningb
Present (n [ 27) Absent (n [ 36) P ‡7 days (n [ 33) £6 days (n [ 30) P
Creatinine (mg/dL) 1.4 2.0 (7.4) 0 (0.0) 0.180 2 (6.1) 0 (0.0) 0.493
Albumin (g/dL) 3.4 13 (48.1) 16 (44.4) 0.803 17 (51.5) 12 (40.0) 0.450
Abbreviations: ASA = American Society of Anesthesiologists; BMI = body mass index; DASI = Duke activity status index; FTSTS = five times sit-to-
stand; HGS = hand grip strength; MET = metabolic equivalent of task; SRT = steep ramp test; TUG = timed up-and-go; VSAQ = veterans-specific
activity questionnaire; WBC = white blood cells; WRpeak = peak work rate; 2MWT = two-minute walk test.
P values <0.05 was considered statistically significant which are mentioned in bold.
a Major complications are complications with Clavien-Dindo grade  III.
b Median time to recovery of physical functioning in the current study cohort equaled 6.5 days.
c Values are expressed as median (range).
Table 3 Multivariable logistic regression for major complications and recovery of physical functioning above its median value in the current
study cohort
Covariate Regression coefficient OR (95% CI interval) AUC P
Major complication (Clavien-Dindo grade  III) ASA grade III 1.252 3.498 (1.033–11.852) 0.620 0.044
Platelet count (103 cells/mm3) 0.005 1.005 (1.000–1.010) 0.673 0.038
Time to recovery of physical
functioning (7 days)
SRT (WRpeak/kg) −1.058 0.347 (0.141–0.854) 0.680 0.021
Abbreviations: ASA = American Society of Anesthesiologists; AUC = area under the curve; CI = confidence interval; SRT = steep ramp test;
WRpeak = peak work rate.
P values <0.05 was considered statistically significant which are mentioned in bold.
Figure 2 Performance of risk prediction models for major morbidity demonstrated by ROC curve and calibration curves for risk prediction model
of Wiltberger et al.9 (upper panel) and Kelly et al.34 (lower panel)
HPB 2020, 22, 716–727 © 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
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Table 4 Demographics and level of physical functioning of patients undergoing pancreatic resection with a higher (composite endpoint 1)
and lower (composite endpoint 2) impact of a major complications
Composite
endpoint 1a
Composite
endpoint 2b
Present (n [ 22) Present (n [ 5) P
Sex ratio (M:F) 11:11 4:1 0.342
Age (years)c 73.0 (26.0–85.0) 61.0 (56.0–72.0) 0.026
<70 6 (27.3) 4 (80.0) 0.015
70 16 (72.2) 1 (20.0)
BMI (kg/m2)c 26.1 (19.1–39.3) 24.7 (20.8–26.7) 0.525
Normal
(18.5–24.9)
7 (31.8) 3 (60.0)
Overweight
(25.0–29.9)
11 (50.0) 2 (40.0)
Obese (30.0) 4 (18.2) 0 (0.0)
ASA 0.370
Grade I– II 14 (63.6) 2 (40.0)
Grade  III 8 (36.4) 3 (60.0)
Comorbidities 1.000
None 3 (13.6) 1 (20.0)
1 comorbidity 3 (13.6) 1 (20.0)
2 comorbidities 16 (72.7) 3 (60.0)
Functional status 0.636
Independent 14 (63.6) 4 (80.0)
Dependent 8 (36.4) 1 (20.0)
Physical functioningc
SRT (WRpeak) 160.0
(67.0–301.00)
201.0 (162.0–239.0) 0.062
SRT (WRpeak/kg) 2.07 (0.92–3.13) 2.89 (1.87–4.12) 0.047
HGS (kg) 31.0 (15.0–59.0) 36.0 (29.0–56.0) 0.277
FTSTS test (s) 8.91 (4.78–28.93) 6.94 (5.44–14.07) 0.314
TUG test (s) 5.61 (3.32–21.25) 4.16 (3.59–4.44) 0.063
2MWT (m) 162.0 (55.0–193.0) 197.0 (175.0–240.0) 0.001
VSAQ (MET) 5.5 (3.0–11.0) 9.0 (8.0–11.0) 0.091
DASI (MET) 6.1 (3.1–9.0) 7.3 (5.9–9.9) 0.049
Complication grade 0.255
Grade IIIa 9 (40.9) 3 (60.0)
Grade IIIb 0 (0.0) 1 (20.0)
Grade IV 10 (45.5) 1 (20.0)
Grade V 3 (13.6) 0 (0.0)
Abbreviations: ASA = American Society of Anesthesiologists; BMI = body mass index; DASI = Duke activity status index; FTSTS = five times sit-to-
stand; HGS = handgrip strength; MET = metabolic equivalent of task; SRT = steep ramp test; TUG = timed up-and-go; VSAQ = veterans-specific
activity questionnaire; WRpeak = peak work rate; 2MWT = two-minute walk test.
P values <0.05 was considered statistically significant which are mentioned in bold.
a Major complication and a time to recovery of physical functioning above its median value (7 days, higher impact).
b Major complication and a time to recovery of physical functioning below its median value (6 days, lower impact).
c Values are expressed as median (range).
724 HPBpancreaticoduodenectomy8 in previous studies. Surprisingly,
(estimated) aerobic capacity was not related with the devel-
opment of a postoperative complication in the present study,HPB 2020, 22, 716–727 © 2019 International Hepato-Pwhich is not in line with findings from other studies.20–22 The
group without a major complication had a tendency to a higher
absolute and relative preoperative WRpeak at the SRT comparedancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
HPB 725to the group who experienced a major complication (Table 2).
One possible explanation could be the type of test that was
used to estimate aerobic capacity: a SRT instead of a cardio-
pulmonary exercise test (the gold standard). Although, we did
not find the same association between preoperative
performance-tests of physical functioning and major compli-
cations as established in other studies.25,45 A post hoc analysis
was performed to evaluate differences in postoperative out-
comes between patients who underwent pancreaticoduode-
nectomy (n = 47) and patients who underwent distal
pancreatectomy (n = 13). By doing so differences were found
in time to recovery of physical functioning (7.5 versus 4.0 days,
respectively; P = 0.055), complication incidence (78.7% versus
46.2%, respectively; P = 0.035), major complications (48.9%
versus 23.1%, respectively; P = 0.122), and length of hospital
stay (14.5 days versus 9.0 days, respectively; P = 0.049). In
future observational studies these findings should be taken into
account, preferably already in the setup of the studies in order
to have sufficient power to introduce different types of surgery
in the analysis. Furthermore, it is also of interest to study the
association between the preoperative (natural) course (change
scores) of physical fitness and physical activity level of the
patient (improved, stable, declined) and postoperative out-
comes, or to assess the effect of a preoperative exercise inter-
vention combined with nutritional support.
A limited number of useful clinical models is currently
available in the literature to predict major complications in
patients undergoing pancreatic resection (Supplemental file 2,
Table 1). Performance of prediction models is often lower in
the external validation cohort compared to the cohort in
which the prediction model was developed.46 This might be
attributed to (i) the context in which the risk-prediction
model is developed and validated (e.g. hospital-specific care
pathways and protocols), (ii) heterogeneity in defining
(major) complications (Clavien-Dindo  III) in the different
prediction models,9,34 (iii) the type of surgery for which the
risk-prediction model was developed, and (iv) methodology
and sample size considerations (e.g. the impact of sample size
and the number of events on the performance of prognostic
models47). The model of Kelly et al.34 was externally validated
on all types of pancreatic surgery in the current study cohort,
whereas it was developed merely for patients undergoing a
distal pancreatectomy. The latter could be a possible expla-
nation of its low predictive performance in the present
cohort. The usefulness of the model of Wiltberger et al.9 in
daily clinical practice was further evaluated in a post-hoc
analysis. The positive predictive value was 64.3% and the
negative predicted value was 74.3%. The positive predictive
value is relatively low; thus, only a small proportion of those
considered at risk actually develop complications. Available
models in the literature merely contain conventional pre-
dictors (e.g. age, comorbidities) for postoperative major
complications. Predictors related to preoperative physicalHPB 2020, 22, 716–727 © 2019 International Hepato-Pfunctioning (e.g. aerobic capacity) should be added to further
improve the accuracy of preoperative risk stratification.
Furthermore, the assessment of muscle mass with the use of
computed tomographyin in combination with performance-
based tests may provide additive risk prediction accuracy
and the ability to develop targeted preoperative
interventions.48
Concerning the impact of a major complication, its relation
with time to recovery of physical functioning was explored.
There was an independent statistically significant difference be-
tween age and level of physical functioning between patients who
experienced a major complication with a delayed recovery of
physical functioning compared to patients who experienced a
major complication without a delayed recovery of physical
functioning (Table 4). Patients who were younger, patients with a
higher preoperative level of physical functioning (SRT and
2WMT performances), and patients with a higher perceived level
of functional capacity to perform activities of daily life (DASI)
were more likely to better cope with a major postoperative
complication. Present study results are in line with a post-hoc
analysis from Hulzebos et al.49 The study reported that patients
who received preoperative inspiratory muscle training seemed to
cope better with postoperative pneumonia compared to patients
in the usual care-group (without this type of training), as their
median hospitalization was shorter (11.5 versus 13.0 days,
respectively).49 Hence, fitter patients might be more resistant and
might cope better with the negative effects of postoperative
complications. However, results in the current study showed a
large range in preoperative physical functioning in patients
experiencing major complications that had a time to recovery of
physical functioning above its median value in the current study
cohort. Nevertheless, it is hypothesized that a postoperative
complication has less impact in fitter patients. Further research is
required to investigate this hypothesis, as well as to look for al-
ternatives outcome measures for evaluating the impact of a
postoperative complication.
In conclusion, preoperative prediction of postoperative
outcomes is feasible but needs another approach, as existing
risk prediction models to predict major complications in
patients undergoing major pancreatic surgery may have a
limited role in clinical practice given their predictive perfor-
mance. Only conventional predictors are used in currently
available models and the current study shows that there
might be room for improvement by also including variables
of preoperative physical functioning. Furthermore, it is
debatable whether optimal outcome measures are used by
evaluating the incidence of complications without taking its
impact into account.
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